Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study

Recently, the development of once-weekly incretin-based injections dulaglutide and semaglutide has drawn a great deal of attention. This study is aimed at comparing the efficacy of once-weekly GLP-1 receptor activator (GLP-1RA) dulaglutide and semaglutide on glycemic control and several metabolic pa...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Tomohiko Kimura, Masato Kubo, Kaio Takahashi, Ryo Wamata, Yuichiro Iwamoto, Hideyuki Iwamoto, Yukino Katakura, Junpei Sanada, Yoshiro Fushimi, Masashi Shimoda, Fuminori Tatsumi, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2024-01-01
Sarja:	Journal of Diabetes Research
Linkit:	http://dx.doi.org/10.1155/2024/5880589
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!